EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Significance of Dynamic Free T3 Changes in Critically Ill Patients

Yakup Özgüngör iD, Burak Emre Gilik, Emre Karagöz iD, Hicret Yeniay iD, Mensure Çakırgöz iD, Özlem Melis Korkmaz Özgüngör, İhsan Birol iD, Sıla Seven

Clinics and Practice · 30.04.2026 · 16 (5) · 87

DOI: 10.3390/clinpract16050087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinics and Practice, online erschienen am 30.04.2026. Verfasst von Yakup Özgüngör und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Intensive Care Unit, İzmir City Hospital, Izmir 35530, Turkey. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-thyroidal illness syndrome is frequent in critically ill patients, but the prognostic value of dynamic changes in thyroid function tests remains unclear. This study evaluated whether serial measurements of thyroid-stimulating hormone (TSH) and free triiodothyronine (FT3) provide additional predictive value for 30-day mortality beyond conventional severity scores in ICU patients.

Methods

This single-center retrospective observational study included 74 adult patients treated for ≥72 h in a general ICU who had TSH and FT3 measured within 24 h of admission and repeated at 48–72 h. Patients aged 18 years or above admitted to the intensive care unit were included in the study. Demographic characteristics, comorbidities, APACHE II, SOFA, modified NUTRIC (mNUTRIC) scores, and routine laboratory data (including albumin, CRP, and lactate) were recorded. The primary outcome was 30-day mortality. Between-group comparisons were performed using t-tests, Mann–Whitney U, and Chi-square tests. Variables significant in univariate analyses were entered into binary logistic regression models, and predictive performance was assessed using receiver operating characteristic (ROC) curves and the Youden index.

Results

The mean age was 68.7 ± 14.7 years, and 41.9% (n = 31) of the patients died within 30 days. Non-survivors had higher APACHE II, SOFA, and mNUTRIC scores and lower albumin, lymphocyte count, and second FT3 levels compared with survivors (all p ≤ 0.003). Baseline FT3 and TSH were not associated with mortality, whereas both the subsequent FT3 measurements and the ΔT3 (variance in former to latter FT3) were remarkably predictive. The latter FT3 < 1.63 pg/mL produced an AUC of 0.835 (sensitivity: 77%, specificity: 74%), and a ΔT3 log ratio threshold of −0.09 (≈20% early FT3 decline) produced an AUC of 0.835 (sensitivity: 71%, specificity: 81%). The APACHE II + ΔT3 (numeric) model showed the best discrimination (AUC: 0.921; sensitivity: 87.1%, specificity: 81.4%), outperforming APACHE II alone (AUC: 0.861).

Conclusions

In critically ill adult patients, dynamic T3 kinetics—particularly premature decline in FT3 within the first 72 h—provide incremental prognostic value for 30-day mortality beyond APACHE II. Serial FT3 monitoring may help identify high-risk patients whose endocrine adaptation to critical illness is failing.

Schlagwörter

Stichwörter der Autor:innen

30-day mortalityAPACHEICUSOFAnon-thyroidal illness syndrome (NTIS)thyroid function teststhyroid-stimulating hormone

Autor:innen und Institutionen

  • Department of General Intensive Care Unit, İzmir City Hospital, Izmir 35530, Turkey.
  • Department of General Intensive Care, Balıkesir Atatürk City Hospital, Balıkesir 10185, Turkey.
  • Department of Occupational and Environmental Diseases, Dokuz Eylul University Faculty of Medicine, Izmir 35340, Turkey.
  • Department of Intensive Care, Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, Izmir 35110, Turkey.

ORCID-Profile: Yakup Özgüngör, Emre Karagöz, Hicret Yeniay, Mensure Çakırgöz, İhsan Birol

Zitieren

APA

Özgüngör, Y., Gilik, B. E., Karagöz, E., Yeniay, H., Çakırgöz, M., Özgüngör, Ö. M. K., Birol, İ., & Seven, S. (2026). Prognostic Significance of Dynamic Free T3 Changes in Critically Ill Patients. Clinics and Practice, 16(5), 87. https://doi.org/10.3390/clinpract16050087

Vancouver

Özgüngör Y, Gilik BE, Karagöz E, Yeniay H, Çakırgöz M, Özgüngör ÖMK, et al. Prognostic Significance of Dynamic Free T3 Changes in Critically Ill Patients. Clinics and Practice. 2026;16(5):87. doi:10.3390/clinpract16050087

BibTeX
@article{zgngr2026,
  author = {Özgüngör, Yakup and Gilik, Burak Emre and Karagöz, Emre and Yeniay, Hicret and Çakırgöz, Mensure and Özgüngör, Özlem Melis Korkmaz and Birol, İhsan and Seven, Sıla},
  title = {Prognostic Significance of Dynamic Free T3 Changes in Critically Ill Patients},
  journal = {Clinics and Practice},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {87},
  doi = {10.3390/clinpract16050087}
}
Kostenlos starten →